课题基金 / 基金详情

Integrated Clinicopathology and Biorespository Core

Integrated Clinicopathology and Biorespository Core
综合临床病理学和生物仓库核心
批准号:
8588551
负责人:
Matthew D Ringel
金额:
$27.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-25 至 2018-07-31

项目摘要

项目成果

Matthew D Ringel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of this Core is to provide high quality clinical data and subject samples for use in the scientific projects of the SPORE. To provide these resources. Core A will utilize and expand upon clinical and biospecimen resources that already exist at each institution. For projects in which additional or different samples/data are required, prospective collection of these samples and their corresponding clinical information will be supported through Core A. RELEVANCE (See instructions): Core A is essential to ensure that all research activities in this SPORE utilizing human samples are provided with sound clinical and pathological information, that the data are efficiently and accurately managed, and that distribution of samples and data occurs in a reliable and timely manner.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RCAN 1.4 metastasis suppressor in thyroid cancer
  • 批准号:
    9973560
  • 项目类别:
  • 资助金额:
    $45.25万
  • 财政年份:
    2020
  • 负责人:
    Matthew D Ringel
  • 依托单位:
RCAN 1.4 metastasis suppressor in thyroid cancer
  • 批准号:
    10604328
  • 项目类别:
  • 资助金额:
    $44.53万
  • 财政年份:
    2020
  • 负责人:
    Matthew D Ringel
  • 依托单位:
RCAN 1.4 metastasis suppressor in thyroid cancer
  • 批准号:
    10400004
  • 项目类别:
  • 资助金额:
    $44.34万
  • 财政年份:
    2020
  • 负责人:
    Matthew D Ringel
  • 依托单位:
Role of p21-activated kinases in thyroid cancer
  • 批准号:
    10377551
  • 项目类别:
  • 资助金额:
    $36.76万
  • 财政年份:
    2018
  • 负责人:
    Matthew D Ringel
  • 依托单位:
海外基金